yoda1 shed spheroids (MedChemExpress)
Structured Review

Yoda1 Shed Spheroids, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 134 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/yoda1 shed spheroids/product/MedChemExpress
Average 96 stars, based on 134 article reviews
Images
1) Product Images from "Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt signaling"
Article Title: Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt signaling
Journal: Materials Today Bio
doi: 10.1016/j.mtbio.2025.102620
Figure Legend Snippet: Schematic illustration showing the generation, mechanism, and application of self-mineralized Yoda1+ BOs from Piezo1-activated SHED spheroids .
Techniques Used:
Figure Legend Snippet: Piezo1 activation promotes SHED spheroids assembly through up-regulating adhesion molecules. (A) Illustration of the preparation process of Yoda1+ SEHDs spheroids. (B) Optical microscopy images showing the formation of SHED spheroids within 48 h. (C) The cell viability and morphology of cell spheroids observed by HE staining and live/dead staining. (D) & (E) Immunofluorescence staining to visualize the expression of Piezo1 and the morphology of F-actin cytoskeleton in SHED spheroids. (F) & (G) IHC staining and quantitative analysis to visualize the expression of E-cadherin and N-cadherin. (n ≥ 3) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Techniques Used: Activation Assay, Microscopy, Staining, Immunofluorescence, Expressing, Immunohistochemistry
Figure Legend Snippet: Piezo1 activation enhances the osteogenic potential of SHED spheroids . (A) hBMSCs were cultured with conditioned media of Yoda1+ SHED spheroids. (B) The expressions of RUNX2 and BMP2 genes related to osteogenic differentiation. (C) & (D) IF staining and quantitative analysis to visualize the expression of RUNX2 and BMP2. (E) Wound healing assay and corresponding quantitative analysis on cell migration of hBMSCs. (F) ALP staining and Alizarin red staining. (n ≥ 3) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Techniques Used: Activation Assay, Cell Culture, Staining, Expressing, Wound Healing Assay, Migration
Figure Legend Snippet: Piezo1 activation enhances the angiogenic potential of SHED spheroids . HUVECs were cultured with conditioned media of Yoda1+ SHED spheroids. (A) IHC staining and quantitative analysis to visualize the expression of CD31. (B) The expressions of ANG1 and CD31 genes related to osteogenic differentiation. (C) Wound healing assay and corresponding quantitative analysis on cell migration of HUVECs. (D) In vitro tube formation of HUVECs for neovascularization with corresponding quantitative analysis. (n ≥ 3) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Techniques Used: Activation Assay, Cell Culture, Immunohistochemistry, Expressing, Wound Healing Assay, Migration, In Vitro
Figure Legend Snippet: RNA sequencing of Yoda1+ SHED spheroids. (A) Volcano plot of significantly upregulated and downregulated genes (Yoda1+ vs. Yoda1-). (B) The clustered heatmap of differentially expressed genes in Yoda1+ SHED spheroids compared with Yoda1- SHED spheroids related to mechanical stimulus. (C) KEGG enrichment analysis. (D) The clustered heatmap of differentially expressed genes in Yoda1+ SHED spheroids compared with Yoda1- SHED spheroids related to Wnt signaling pathway. (E) Western blot and quantitative analysis of the expression of markers including Piezo1, WNT7B and RUNX2. (F) The schematic illustration that under Yoda1 stimulation, the Piezo1 channel is activated, triggering the activation Wnt signaling pathway and increased expression of RUNX2. (n ≥ 3) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Techniques Used: RNA Sequencing, Western Blot, Expressing, Activation Assay
Figure Legend Snippet: The formation and characterizations of Yoda1+ BOs. (A) Illustration of the formation process of bone organoids. The BOs were fixed, dehydrated and stained or lysed to extract mRNA for further qPCR assays. (B) IHC staining and quantitative analysis to visualize the expression of RUNX2 and OCN in BOs after osteogenic induction. (C) The expressions of four genes related to osteogenic differentiation of BOs. (D) Scanning electron microscopy (SEM) to observe the surface morphology and elemental distribution of BOs after 14-day osteogenic induction. (n ≥ 3) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Techniques Used: Staining, Immunohistochemistry, Expressing, Electron Microscopy
Figure Legend Snippet: Yoda1+ BOs promotes calvarial bone regeneration. (A) A schematic illustration showing the design of the in vivo study. (B) Micro-CT images, (C) BV/TV values, and BMD values of various groups. The diameter of red circles = 3 mm. (D) Histological analysis by H&E, Masson's trichrome staining and IHC staining of OPN and OCN of calvarial bone sections. (n ≥ 3) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Techniques Used: In Vivo, Micro-CT, Staining, Immunohistochemistry
